American Biodefense

Biological weapons have threatened U.S. national security since at least World War II. Historically, however, the U.S. military has neglected research, development, acquisition, and doctrine for biodefense. Following September 11 and the anthrax letters of 2001, the United States started spending billions of dollars per year on medical countermeasures and biological detection systems. But most of this funding now comes from the Department of Health and Human Services rather than the Department of Defense. Why has the U.S. military neglected biodefense and allowed civilian organizations to take the lead in defending the country against biological attacks? In American Biodefense, Frank L. Smith III addresses this puzzling and largely untold story about science, technology, and national security.Smith argues that organizational frames and stereotypes have caused both military neglect and the rise of civilian biodefense. In the armed services, influential ideas about kinetic warfare have undermined defense against biological warfare. The influence of these ideas on science and technology challenges the conventional wisdom that national security policy is driven by threats or bureaucratic interests. Given the ideas at work inside the U.S. military, Smith explains how the lessons learned from biodefense can help solve other important problems that range from radiation weapons to cyber attacks.

In the years since the 9/11 attacks—and the subsequent lethal anthrax letters—the United States has spent billions of dollars on measures to defend the population against the threat of biological weapons. But as Lynn C. Klotz and Edward J. Sylvester argue forcefully in Breeding Bio Insecurity, all that money and effort hasn’t made us any safer—in fact, it has made us more vulnerable. Breeding Bio Insecurity reveals the mistakes made to this point and lays out the necessary steps to set us on the path toward true biosecurity. The fundamental problem with the current approach, according to the authors, is the danger caused by the sheer size and secrecy of our biodefense effort. Thousands of scientists spread throughout hundreds of locations are now working with lethal bioweapons agents—but their inability to make their work public causes suspicion among our enemies and allies alike, even as the enormous number of laboratories greatly multiplies the inherent risk of deadly accidents or theft. Meanwhile, vital public health needs go unmet because of this new biodefense focus. True biosecurity, the authors argue, will require a multipronged effort based in an understanding of the complexity of the issue, guided by scientific ethics, and watched over by a vigilant citizenry attentive to the difference between fear mongering and true analysis of risk. An impassioned warning that never loses sight of political and scientific reality, Breeding Bio Insecurity is a crucial first step toward meeting the evolving threats of the twenty-first century.

Scientific advances over the past several decades have accelerated the ability to engineer existing organisms and to potentially create novel ones not found in nature. Synthetic biology, which collectively refers to concepts, approaches, and tools that enable the modification or creation of biological organisms, is being pursued overwhelmingly for beneficial purposes ranging from reducing the burden of disease to improving agricultural yields to remediating pollution. Although the contributions synthetic biology can make in these and other areas hold great promise, it is also possible to imagine malicious uses that could threaten U.S. citizens and military personnel. Making informed decisions about how to address such concerns requires a realistic assessment of the capabilities that could be misused. Biodefense in the Age of Synthetic Biology explores and envisions potential misuses of synthetic biology. This report develops a framework to guide an assessment of the security concerns related to advances in synthetic biology, assesses the levels of concern warranted for such advances, and identifies options that could help mitigate those concerns.

In the United States, the National Biodefense Strategy is a biosecurity strategy that the federal government was directed to adopt by the National Defense Authorization Act for Fiscal Year 2017. Following the congressional directive, in September 2018, President Trump announced and issued the strategy. The strategy placed the U.S. Department of Health and Human Services in charge of leading the federal government's biodefense efforts, and designated HHS to lead a committee of high-level officials from the Defense Department, Agriculture Department, and Homeland Security Departments, to review the biodefense capabilities of the United States Intelligence Community and 15 other executive branch agencies.

In 2001, following the events of September 11 and the Anthrax attacks, the United States government began an aggressive campaign to secure the nation against biological catastrophe. Its agenda included building National Biocontainment Laboratories (NBLs), secure facilities intended for research on biodefense applications, at participating universities around the country. In Community at Risk, Thomas D. Beamish examines the civic response to local universities' plans to develop NBLs in three communities: Roxbury, MA; Davis, CA; and Galveston, TX. At a time when the country's anxiety over its security had peaked, reactions to the biolabs ranged from vocal public opposition to acceptance and embrace. He argues that these divergent responses can be accounted for by the civic conventions, relations, and virtues specific to each locale. Together, these elements clustered, providing a foundation for public dialogue. In contrast to conventional micro- and macro-level accounts of how risk is perceived and managed, Beamish's analysis of each case reveals the pivotal role played by meso-level contexts and political dynamics. Community at Risk provides a new framework for understanding risk disputes and their prevalence in American civic life.

Pathogens for War explores how Canada and its allies have attempted to deal with the threat of germ warfare, one of the most fearful weapons of mass destruction, since the Second World War. In addressing this subject, distinguished historian Donald Avery investigates the relationship between bioweapons, poison gas, and nuclear devices, as well as the connection between bioattacks and natural disease pandemics. Avery emphasizes the crucially important activities of Canadian biodefence scientists – beginning with Nobel Laureate Frederick Banting – at both the national level and through cooperative projects within the framework of an elaborate alliance system. Delving into history through a rich collection of declassified documents, Pathogens for War also devotes several chapters to the contemporary challenges of bioterrorism and disease pandemics from both national and international perspectives. As such, readers will not only learn about Canada’s secret involvement with biological warfare, but will also gain new insights into current debates about the peril of bioweapons – one of today’s greatest threats to world peace.

It is nearly 15 years since biological weapons (BW) have become a significant national security preoccupation. The events of September 11, 2001, although not in any way related to BW, combined with the distribution of professionally prepared anthrax spores through the U.S. postal system in the weeks afterwards, magnified previous concerns by orders of magnitude.

Biosecurity and Bioterrorism, Second Edition, takes a holistic approach to biosecurity, with coverage of pathogens, prevention, and response methodology. It addresses these hazards in the context of vulnerability assessments and the planning strategies government and industry can use to prepare for and respond to such events. The book is organized into four thematic sections: Part I provides a conceptual understanding of biowarfare, bioterrorism and the laws we have to counteract this; Part II investigates known bioagents and the threat from emerging diseases; Part III focuses on agricultural terrorism and food security; and Part IV outlines international, US, and local initiatives for biodefense and biosecurity. Case studies illustrate biodefense against both intentional terrorism and natural outbreaks. Covers emerging threats of pandemic influenza, antibiotic resistant strains of bacterial pathogens, and severe respiratory diseases caused by novel viruses Offers increased international coverage, including initiatives to counter biological weapons and threats, and food security Updated throughout with latest protocols for dealing with biological threats and new case studies Includes online instructor ancillaries - PowerPoint lecture slides, test questions, and an instructor manual, for increased classroom functionality